Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Retinal drugs are the medications that are used for the treatment of retinal diseases
North America dominated the global retinal drugs market in 2017
The report details the trend, potential and market size of Retinal Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Drugsmarket, defines the market attractiveness level of Retinal Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Retinal Drugs industry, describes the types of Retinal Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Drugs market and the development prospects and opportunities of Retinal Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Drugs market in Chapter 13.
By Player:
Teva Pharmaceutical
Merck
Novartis
ThromboGenics
Bayer
F Hoffmann-La Roche
Regeneron
Shire
By Type:
Wet AMD
Diabetic Retinopathy
DME
RVO
Mcnv
By End-User:
Hospitial
Clinicl
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Retinal Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Retinal Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Retinal Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Retinal Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Retinal Drugs Market Analysis and Outlook to 2022
-
7.1 Global Retinal Drugs Consumption (2017-2022)
-
7.2 United States Retinal Drugs Consumption (2017-2022)
-
7.3 Europe Retinal Drugs Consumption (2017-2022)
-
7.4 China Retinal Drugs Consumption (2017-2022)
-
7.5 Japan Retinal Drugs Consumption (2017-2022)
-
7.6 India Retinal Drugs Consumption (2017-2022)
-
7.7 South Korea Retinal Drugs Consumption (2017-2022)
8 Region and Country-wise Retinal Drugs Market Analysis and Outlook to 2028
-
8.1 Global Retinal Drugs Consumption Forecast (2022-2028)
-
8.2 United States Retinal Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Retinal Drugs Consumption Forecast (2022-2028)
-
8.4 China Retinal Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Retinal Drugs Consumption Forecast (2022-2028)
-
8.6 India Retinal Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Retinal Drugs Consumption Forecast (2022-2028)
9 Global Retinal Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Retinal Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Wet AMD Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DME Consumption and Growth Rate (2017-2022)
-
9.1.4 Global RVO Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Mcnv Consumption and Growth Rate (2017-2022)
-
9.2 Global Retinal Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitial Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinicl Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Retinal Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Retinal Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global DME Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global RVO Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Mcnv Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Retinal Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitial Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinicl Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Retinal Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Retinal Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Retinal Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Retinal Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Retinal Drugs Market Competitive Analysis
-
14.1 Teva Pharmaceutical
-
14.1.1 Teva Pharmaceutical Company Details
-
14.1.2 Teva Pharmaceutical Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical Retinal Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Retinal Drugs Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Retinal Drugs Product and Service
-
14.4 ThromboGenics
-
14.4.1 ThromboGenics Company Details
-
14.4.2 ThromboGenics Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ThromboGenics Retinal Drugs Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Retinal Drugs Product and Service
-
14.6 F Hoffmann-La Roche
-
14.6.1 F Hoffmann-La Roche Company Details
-
14.6.2 F Hoffmann-La Roche Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 F Hoffmann-La Roche Retinal Drugs Product and Service
-
14.7 Regeneron
-
14.7.1 Regeneron Company Details
-
14.7.2 Regeneron Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Regeneron Retinal Drugs Product and Service
-
14.8 Shire
-
14.8.1 Shire Company Details
-
14.8.2 Shire Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire Retinal Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Retinal Drugs
-
Figure Retinal Drugs Picture
-
Table Global Retinal Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Retinal Drugs Consumption by Country (2017-2022)
-
Figure United States Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Retinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Retinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wet AMD Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)
-
Figure Global DME Consumption and Growth Rate (2017-2022)
-
Figure Global RVO Consumption and Growth Rate (2017-2022)
-
Figure Global Mcnv Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitial Consumption and Growth Rate (2017-2022)
-
Figure Global Clinicl Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DME Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RVO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mcnv Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinicl Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Retinal Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Retinal Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Retinal Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Retinal Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Retinal Drugs Product and Service
-
Table ThromboGenics (Foundation Year, Company Profile and etc.)
-
Table ThromboGenics Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ThromboGenics Retinal Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Retinal Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Retinal Drugs Product and Service
-
Table Regeneron (Foundation Year, Company Profile and etc.)
-
Table Regeneron Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Retinal Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Retinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Retinal Drugs Product and Service
-
